ArticleCancer medicine2022

The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer.

Hanxiao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.